MoneyWorks4Me

Marksans Pharma receives EIR from USFDA for Goa facility

06 Jun 2019 Evaluate

Marksans Pharma has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Goa facility. The inspection at the company's facility was carried out from February 25 to March 06, 2019.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..